XML 49 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2017
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS  
Summary of securities included in cash and cash equivalents and short-term investments

Securities classified as cash and cash equivalents and short-term investments as of December 31, 2017 and 2016 are summarized below (in thousands). Estimated fair value is based on quoted market prices for these investments.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

Gross

    

Gross

    

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

 

 

 

December 31, 2017

 

Cost

 

Gains

 

Losses

 

Fair Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

103,119

 

$

 —

 

$

 —

 

$

103,119

 

Money market funds

 

 

95

 

 

 —

 

 

 —

 

 

95

 

Commercial paper

 

 

23,670

 

 

 —

 

 

 —

 

 

23,670

 

Total cash and cash equivalents

 

 

126,884

 

 

 —

 

 

 —

 

 

126,884

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities and commercial paper with maturities less than 1 year

 

 

1,210

 

 

 —

 

 

(5)

 

 

1,205

 

Total short-term investments

 

 

1,210

 

 

 —

 

 

(5)

 

 

1,205

 

Total

 

$

128,094

 

$

 —

 

$

(5)

 

$

128,089

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

Gross

    

Gross

    

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

 

 

 

December 31, 2016

 

Cost

 

Gains

 

Losses

 

Fair Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

87,845

 

$

 —

 

$

 —

 

$

87,845

 

Money market funds

 

 

532

 

 

 —

 

 

 —

 

 

532

 

Corporate debt securities and commercial paper

 

 

29,334

 

 

 —

 

 

(2)

 

 

29,332

 

Total cash and cash equivalents

 

 

117,711

 

 

 —

 

 

(2)

 

 

117,709

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities and commercial paper with maturities less than 1 year

 

 

59,728

 

 

 —

 

 

(17)

 

 

59,711

 

Total short-term investments

 

 

59,728

 

 

 —

 

 

(17)

 

 

59,711

 

Total

 

$

177,439

 

$

 —

 

$

(19)

 

$

177,420

 

 

Schedule of the gross unrealized losses and fair value of investments

The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses that are not deemed to be other‑than‑temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at December 31, 2017 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less than 12 months

 

12 months or greater

 

Total

 

 

    

 

 

    

Gross

    

 

 

    

Gross

    

 

 

    

Gross

 

 

 

 

 

 

Unrealized

 

 

 

 

Unrealized

 

 

 

 

Unrealized

 

 

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

Corporate debt securities

 

$

1,205

 

$

(5)

 

$

 —

 

$

 —

 

$

1,205

 

$

(5)

 

 

Schedule of fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis

The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2017 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2017

    

Level 1

    

Level 2

    

Level 3

    

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

95

 

$

 —

 

$

 —

 

$

95

 

Commercial paper

 

 

 —

 

 

23,670

 

 

 —

 

 

23,670

 

Corporate debt securities

 

 

 —

 

 

1,205

 

 

 —

 

 

1,205

 

Total

 

$

95

 

$

24,875

 

$

 —

 

$

24,970

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration—Zipsor

 

$

 —

 

$

 —

 

$

464

 

$

464

 

Contingent consideration—Lazanda

 

 

 —

 

 

 —

 

 

156

 

 

156

 

Contingent consideration—CAMBIA

 

 

 —

 

 

 —

 

 

993

 

 

993

 

Total

 

$

 —

 

$

 —

 

$

1,613

 

$

1,613

 

 

The following table represents the Company’s fair value hierarchy for its financial assets measured at fair value on a recurring basis as of December 31, 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2016

    

Level 1

    

Level 2

    

Level 3

    

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

532

 

$

 —

 

$

 —

 

$

532

 

Commercial paper

 

 

 —

 

 

52,192

 

 

 —

 

 

52,192

 

Corporate debt securities

 

 

 —

 

 

36,850

 

 

 —

 

 

36,850

 

Total

 

$

532

 

$

89,042

 

$

 —

 

$

89,574

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration—Zipsor

 

$

 —

 

$

 —

 

$

1,489

 

$

1,489

 

Contingent consideration—Lazanda

 

 

 —

 

 

 —

 

 

11,742

 

 

11,742

 

Contingent consideration—CAMBIA

 

 

 —

 

 

 —

 

 

1,594

 

 

1,594

 

 

 

$

 —

 

$

 —

 

$

14,825

 

$

14,825

 

 

Summary of the changes in fair value of all financial liabilities measured at fair value on a recurring basis using significant unobservable inputs

 

 

The table below provides a summary of the changes in fair value recorded in interest expense, selling, general and administrative expense, and gain on divestiture of Lazanda measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2017, 2016 and 2015 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2017

 

2016

 

2015

 

Fair value, beginning of the period

 

$

14,825

 

$

14,971

 

$

17,595

 

Changes in fair value recorded in interest expense

 

 

1,079

 

 

2,408

 

 

2,307

 

Changes in fair value recorded in selling, general and administrative expenses

 

 

(7,708)

 

 

(122)

 

 

(3,684)

 

Royalties and milestone paid

 

 

(3,068)

 

 

(2,432)

 

 

(1,247)

 

Divestiture of Lazanda

 

 

(3,515)

 

 

 -

 

 

 -

 

Total

 

$

1,613

 

$

14,825

 

$

14,971